Nuclear PD-L1: an emerging oncogenic driver and promising therapeutic target in cancer.
Saved in:
| Title: | Nuclear PD-L1: an emerging oncogenic driver and promising therapeutic target in cancer. |
|---|---|
| Authors: | Guo C; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Fan Z; Department of Medical Oncology, Peking University First Hospital, Peking University, Beijing, 100034, China., Guo C; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, 100034, China., Yang Y; Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, 75006, Paris, France. yaning.yang@inserm.fr.; Metabolomics and Cell Biology Platforms, Gustave Roussy Institut, 94805, Villejuif, France. yaning.yang@inserm.fr., Hou H; Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, Shandong, China. houheleihhl@163.com., Sun D; Department of Medical Oncology, Peking University First Hospital, Peking University, Beijing, 100034, China. sundantongerik@163.com. |
| Source: | Journal of biomedical science [J Biomed Sci] 2026 Jun 17; Vol. 33 (1). Date of Electronic Publication: 2026 Jun 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 9421567 Publication Model: Electronic Cited Medium: Internet ISSN: 1423-0127 (Electronic) Linking ISSN: 10217770 NLM ISO Abbreviation: J Biomed Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
